Immunotherapy, an innovative approach to cancer treatment, is rapidly evolving as a frontline strategy in the fight against a variety of malignancies. This article aims to provide physicians with a comprehensive understanding of the key aspects of immunotherapy, from its basic principles to its clinical applications.
Immunotherapy, also known as biological therapy, is a type of cancer treatment designed to boost the body's natural defenses to fight cancer. It uses substances made by the body or in a laboratory to improve or restore immune system function. The key to immunotherapy lies in its ability to harness the power of the patient's immune system, enabling it to detect and target cancer cells more effectively.
There are several types of immunotherapy, including monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines, and CAR T-cell therapy. Monoclonal antibodies are designed to bind to specific targets on cancer cells, while immune checkpoint inhibitors help the immune system recognize and attack cancer cells. Cancer vaccines work by triggering the immune system to attack specific diseases, and CAR T-cell therapy involves modifying T cells to enhance their ability to fight cancer.
Immunotherapy has shown promising results in treating various types of cancer, such as melanoma, lung, kidney, bladder, and head and neck cancers. However, not all patients respond to immunotherapy, and it can cause side effects, including inflammation and immune-related adverse events. Determining which patients will benefit from immunotherapy remains a significant challenge in the field.
Immunotherapy represents a groundbreaking shift in cancer treatment, offering new hope to patients who have previously exhausted all other options. As our understanding of the immune system's role in cancer continues to evolve, it's crucial for physicians to stay abreast of the latest advancements and applications of immunotherapy to provide the best possible care for their patients.
1.
The White House has postponed its plan to outlaw menthol cigarettes indefinitely.
2.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
3.
Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.
4.
Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.
5.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
1.
Understanding the Importance of Knowing Your MCV Normal Range
2.
Modern Concepts in Oncology Across Clinical Settings
3.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
4.
Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development
5.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation